Journey Medical Corp
DERM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867066
No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Journey Medical Corp changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 0 | 14 | +14 |
| Shares | 0 | 1.63M | +1.63M |
| Value | $0 | $8.76M | +$8.76M |
New holders (14)
Institutions that held Journey Medical Corp at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| B. Riley Financial, Inc. | 864,695 | $4.65M | 0.52% |
| Neuberger Berman Group LLC | 199,112 | $1.07M | 0.00% |
| American Financial Group Inc | 180,000 | $968.0K | 0.27% |
| Perkins Capital Management Inc | 140,800 | $758.0K | 0.51% |
| Millrace Asset Group, Inc. | 113,862 | $613.0K | 0.36% |
| Cannell Capital LLC | 41,108 | $221.0K | 0.04% |
| Goldman Sachs Group Inc | 35,820 | $193.0K | 0.00% |
| B. Riley Wealth Management, Inc. | 15,000 | $81.0K | 0.01% |
| Citadel Advisors LLC | 10,761 | $58.0K | 0.00% |
| Tudor Investment Corp Et Al | 10,602 | $57.0K | 0.00% |
| BlackRock Inc. | 9,328 | $50.0K | 0.00% |
| UBS Group AG | 3,248 | $17.0K | 0.00% |
| Royal Bank of Canada | 2,500 | $13.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 656 | $4.00K | 0.00% |
Sold out (0)
Institutions that held Journey Medical Corp at the end of Q3 2021 and filed for Q4 2021 without it.
None.